Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guillermo Garcia‐Manero
Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-Cvd, With or Without Blinatumomab, Is Highly Effective in Patients With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Salvage
Cancer
Cancer Research
Oncology
The Distribution of T-Cell Subsets and the Expression of Immune Checkpoint Receptors and Ligands in Patients With Newly Diagnosed and Relapsed Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Related publications
Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia
Advances in Therapy
Medicine
Pharmacology
Initial Experience With CMC-544 (Inotuzumab Ozogamicin) in Pediatric Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Assessment of Clinical Immunogenicity of Inotuzumab Ozogamicin in Patients With Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
AAPS Open
Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Drugs and Therapy Studies
Efficacy and Safety Analysis by Age Cohort of Inotuzumab Ozogamicin in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Enrolled in INO-VATE
Cancer
Cancer Research
Oncology
Treatment of Young Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Hyper-Cvad Versus Pediatric-Inspired Regimens
American Journal of Hematology
Hematology
Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
